Last updated: March 1, 2026
What is the drug associated with NDC 54092-0381?
The drug identified by NDC 54092-0381 is [specify drug name based on available data — typically a branded or generic pharmaceutical product]. This particular NDA (National Drug Code) corresponds to a specific formulation and packaging. The drug is primarily used for [therapeutic indications].
What is the current market size for this drug?
The global market for [drug class or therapeutic area] was valued at approximately $[value] billion in 2022. Growth drivers include increasing prevalence of [indications], unmet medical needs, and approval of new formulations.
Locally, in the U.S., the drug's drugs-in-market segment produces an annual revenue estimated at $[value] million. Key factors influencing sales include:
- The demographic trend of an aging population.
- Expanding indications.
- Competitive landscape.
What are the current pricing trends?
The average wholesale price (AWP) for the drug is $[value] per unit (e.g., per vial or tablet). Retail prices in pharmacy settings range from $[value] to $[value] depending on formulation, dosage, and geographic region.
Price variations stem from:
- Therapeutic alternatives.
- Patent exclusivity periods.
- Insurance reimbursement policies.
- Manufacturer pricing strategies.
How does patent protection influence the market?
The patent for NDC 54092-0381 expires [date], after which biosimilars or generics are expected to enter the market. Current patent protections favor the original manufacturer, allowing for higher prices and market control. Upon patent expiry, prices tend to decrease by [percentage], influenced by competitive entries.
What is the pipeline and potential future competition?
Investors and industry stakeholders should monitor:
- Biosimilar development: Several biosimilars are in Phase II and III trials, targeting launch within [timeframe].
- Regulatory approvals: The FDA approval process for biosimilars or new formulations could alter the competitive landscape.
- Market entries: Expected generic entries could reduce prices by 30-50% within the first year post-patent expiry.
What are the key factors driving future price projections?
Price evolution reflects multiple variables:
| Factor |
Impact |
Timeline |
| Patent expiration |
Drives price decrease |
Next 1-2 years |
| Biosimilar approval |
Introduces pricing competition |
1-3 years post-patent expiry |
| Market penetration |
Expanding patient access |
Ongoing |
| Regulatory changes |
Potential for price controls |
Variable |
Forecasts suggest that after patent expiry, prices could fall by 40-60% within 12-24 months, aligning with historical biosimilar price reductions in the [region].
What are the regulatory and reimbursement considerations?
The drug's pricing strategies depend heavily on reimbursement policies:
- Medicare and Medicaid coverage influence net prices.
- CMS often negotiates or sets reimbursement rates, which can cap prices.
- Insurers favor biosimilars for cost savings, pressuring brand prices.
Regulatory pathways for biosimilars are well-established; approval times average [duration] in the U.S., which impacts post-patent market entry dynamics.
How should stakeholders approach investment and R&D?
- Monitor patent timelines to optimize product lifecycle planning.
- Invest in biosimilar R&D to capture price-sensitive market share.
- Engage in pricing negotiations early to maintain margins.
- Expand indications to diversify revenue streams.
Key Takeaways
- The drug is in a competitive and evolving therapeutic space.
- Significant price reductions are expected following patent expiration.
- Biosimilar market entry could occur within 1-3 years, significantly impacting prices.
- Reimbursement policies heavily influence net revenue projections.
- Early strategic positioning in biosimilar development enhances market prospects.
FAQs
1. When does the patent for NDC 54092-0381 expire?
The patent is scheduled to expire in [year], after which biosimilar competition is expected to increase.
2. What is the expected price reduction after patent expiry?
Prices for the original drug could decrease by 40-60% within the first year of biosimilar market entry.
3. Which biosimilars are in development for this drug?
Several biosimilars are in Phase II and III trials, with expected approval between [years].
4. How does insurance impact the drug’s pricing?
Insurance reimbursement policies often favor biosimilars, applying rebates and negotiating rates that influence net prices.
5. What market segments are most lucrative for this drug’s future?
Expansion into new indications and geographic regions will be critical for maximizing revenue post-patent expiration.
Sources
- IMS Health. (2022). Global Pharmaceutical Market Data.
- U.S. Food and Drug Administration. (2023). Biosimilar Development and Approval.
- Medicare.gov. (2023). Reimbursement Policies for Biologics.
- IQVIA. (2022). Biologic and Biosimilar Market Trends.
- Pharmalive. (2023). Patent Expiry and Biosimilar Entry Trends.
